Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression. Atallah NM, Haque M, Quinn C, Toss MS, et al. Eur J Cancer 2023;195:113371.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Atallah NM, Haque M, Quinn C, Toss MS, et al. Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression. Eur J Cancer 2023;195:113371.
PMID: 37897865